TrialClinical and vaccine immunology : CVI2010

Randomized trial on the safety, tolerability, and immunogenicity of MenACWY-CRM, an investigational quadrivalent meningococcal glycoconjugate vaccine, administered concomitantly with a combined tetanus, reduced diphtheria, and acellular pertussis vaccine in adolescents and young adults.

Roberto Gasparini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.